Abstract # 2660 Bexxar (Tositumomab) Protocol CP98-020: Results with I-131 Labeled Antibody in Patients with Follicular Non-Hodgkin's Lymphoma Refractory to Chemotherapy and Rituxan (Rituximab): 5 Year Follow-Up in 60 Cases

Presenter: Robin Akins


Abstract:


E-mail a friend about this poster:
Enter email address: